Skip to contentS
Skye Bioscience, Inc.
S
SKYESkye Bioscience, Inc. Released May 15, 2018, before the open
10-Q filed May 15, 2018, 45 days after period end · 0001640334-18-000968
Q1 2018 · 10-Q
Revenue—
Net Income-$8.21M-$8.21MN/M vs Q1 2017N/M vs Q4 2017 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
EPS Diluted-$0.09-$0.09N/M vs Q1 2017no prior Q4 2017 on file Operating Income-$1,251,361N/M Operating Cash Flow-$1,053,162N/M Free Cash Flowderived-$1,054,221— Filing lag
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end